pep-10484 v1 CC-BY-SA-4.0
Experimental peptide targeting VPAC1 (CHEMBL3102929)
A lab-made peptide that switches on a body receptor tied to inflammation and nerve signaling; still experimental, not an approved medicine.
status
Someone proposed this peptide.
A researcher, an agent, or an algorithm wrote down the sequence and picked a target to hit.
A computer predicted how the peptide binds to its target.
An AI model like OpenFold3 or AlphaFold built a 3D structure and scored how well it fits the binding site.
Someone else ran the same prediction and got the same result.
A second contributor repeated the computation on their own hardware and the scores matched.
The peptide was actually made in a lab.
A chemistry service or a researcher ordered the sequence, it was manufactured, and mass spectrometry confirmed the right molecule was produced.
The peptide was tested on its target in a lab.
A binding or activity measurement confirmed that it actually does what the computer predicted — or didn't.
prediction metrics
ipTM0.840
pTM0.703
avg pLDDT47.8
ranking score0.904
STRUCTURE · PEP-10484 × VPAC1
ranking0.904
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence
151015202528
HSDAVFTDNYTRLR KQIAVKKYLSILGK
details
▸full evidence table1 metrics
| metric | value | tool |
|---|---|---|
| EC50 | 0.21 nM | GPCRDB/ChEMBL |
▸structural qualityopenfold3
| metric | value | note |
|---|---|---|
| gpde | 0.822 | global PDE — lower = better |
| disorder | 0.184 | fraction disordered |
| chain pair ipTM (A, B) | 0.840 | interface quality |
▸3-letter notation
His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Ile-Ala-Val-Lys-Lys-Tyr-Leu-Ser-Ile-Leu-Gly-Lys
▸recipeopenfold3-mlx 0.3.1
| parameter | value |
|---|---|
| model | openfold3-mlx 0.3.1 |
| weights | aedd8f3eb814e392… |
| hardware | apple_m4_base_16gb |
| mlx version | 0.31.1 |
| python | 3.14.3 |
| random seed | 42 |
| msa strategy | colabfold |
| diffusion samples | 1 |
| runtime | 405s |
| predicted by | mlx@peptide |
| predicted at | 2026-04-24 |
python3 openfold3/run_openfold.py predict --query_json {query.json} --runner_yaml examples/example_runner_yamls/mlx_runner.yml --output_dir {output_dir} --num_diffusion_samples 1 ▸citationbibtex
peptidemodel (2026). Experimental peptide targeting VPAC1 (CHEMBL3102929) (pep-10484, v1). PeptideModel. https://peptidemodel.com/card/pep-10484
@peptide{pep10484,
sequence = {HSDAVFTDNYTRLRKQIAVKKYLSILGK},
target = {vpac1},
author = {peptidemodel},
year = {2026},
status = {bioassayed}
} related peptides
clinical trials
0
no registered clinical trials
as of 2026-05-22; we'll re-check periodically
references
discussion
sign in to comment